Abstract
Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Current Bioinformatics
Title:From Ontology-Based Gene Function to Physiological Model
Volume: 7 Issue: 4
Author(s): Ajay Shiv Sharma, Hari Om Gupta and Petar M. Mitrasinovic
Affiliation:
Keywords: Database, functional genomics, gene expression, gene ontology, physiology, systems biology, Model Structure Markup Language, physiology, cellular component ontology, International Nucleotide Sequence Database Collaboration
Abstract: Designing ontology to represent gene function is of vital importance for meeting the major challenge of integrating sequence data with the increasing amount of data from functional analyses of genes. Given that genes are expressed in temporally and spatially characteristic patterns, their products quite often reside in specific cellular compartments and may be part of one or more multi-component complexes. Genes may have more than one product and the products are functionally distinct. An overall strategy elucidating how an ontology-based gene function may be implemented using genomic databases is herein dissected. Knowing that gene products possess one or more biochemical, physiological or structural functions, the present strategy is suggested to lead towards physiological models. A review of the features of the currently available software tools for the implementation of the considered strategy is presented.
Export Options
About this article
Cite this article as:
Shiv Sharma Ajay, Om Gupta Hari and M. Mitrasinovic Petar, From Ontology-Based Gene Function to Physiological Model, Current Bioinformatics 2012; 7 (4) . https://dx.doi.org/10.2174/157489312803901054
DOI https://dx.doi.org/10.2174/157489312803901054 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Armed Oncolytic Adenoviruses and Polymer-shielded Nanocomplex for Systemic Delivery
Current Cancer Therapy Reviews Current Strategies in the Modification of PLGA-based Gene Delivery System
Current Medicinal Chemistry Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
Current Cancer Therapy Reviews Antibodies as Crypts of Antiinfective and Antitumor Peptides
Current Medicinal Chemistry Recent Advances in Inorganic Nanoparticle-Based Drug Delivery Systems
Mini-Reviews in Medicinal Chemistry Alkannins and Shikonins: A New Class of Wound Healing Agents
Current Medicinal Chemistry Withdrawal Notice: COVID-19: Outbreak to Global
Anti-Infective Agents Perspective on Nanoparticle Technology for Biomedical Use
Current Pharmaceutical Design Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Scheduling of Taxanes: A Review
Current Clinical Pharmacology Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance
Current Protein & Peptide Science New Prognostic Markers and Potential Therapeutic Targets in Human Testicular Germ Cell Tumors
Current Medicinal Chemistry Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy
Current Stem Cell Research & Therapy Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues
Anti-Cancer Agents in Medicinal Chemistry Decreased Serum Adiponectin Level Affected Clinical Pathological Characteristics of Patients with Gastric Cancer
Current Proteomics Edelfosine: An Antitumor Drug Prototype
Anti-Cancer Agents in Medicinal Chemistry Simultaneous UPLC-MS/MS Determination of 6-mercaptopurine, 6-methylmercaptopurine and 6-thioguanine in Plasma: Application to the Pharmacokinetic Evaluation of Novel Dosage forms in Beagle Dogs
Current Pharmaceutical Design Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment
Recent Patents on Anti-Cancer Drug Discovery Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Anti-Cancer Agents in Medicinal Chemistry Naturally Occurring δ-Hydroxy-γ-Lactones: Muricatacins and Related Compounds
Current Organic Chemistry